Findings from a clinical trial show a wearable device sending electronic signals into the nervous system relieves migraine pain in children age 12 to 17. . . . → Read More: Neuro Device Shown to Relieve Adolescent Migraine Pain
|
|||||
|
       
  |
 Comments are closed  New products  biomedical, clinical trials, engineering, FDA, Israel, life sciences, medical device, software 
A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock. . . . → Read More: Covid-19 Antibody Developer Raises $483M in IPO One comment - (Comments are closed) Finance biomedical, biotechnology, Canada, clinical trials, Covid-19, equity, FDA, investment, IPO, NIH, pharmaceuticals 
The Food and Drug Administration began a pilot program for assessing alternative technologies to test drugs, biologics, and devices without animals. . . . → Read More: FDA Begins Qualifying Non-Animal Testing Options Comments are closed Regulations biomedical, engineering, FDA, life sciences, medical device, pharmaceuticals, preclinical 
Researchers at University of Pennsylvania and Regeneron are studying delivery of synthetic antibodies directly to the nose to prevent Covid-19 infections. . . . → Read More: Univ, Industry Labs Study Inhaled Covid-19 Antibodies One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, Covid-19, FDA, life sciences, pharmaceuticals, preclinical, university 
Makers of a Covid-19 vaccine given as a nasal spray asked the Food and Drug Administration to authorize a a human clinical trial of the vaccine. . . . → Read More: Trial Requested for Covid-19 Vaccine Nasal Spray 3 comments - (Comments are closed) Joint ventures/collaborations, New products, Regulations biomedical, clinical trials, Covid-19, FDA, life sciences, medical device, pharmaceuticals, preclinical, university 
Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal Comments are closed Intellectual property, Joint ventures/collaborations Australia, biomedical, biotechnology, clinical trials, Covid-19, equity, Europe, FDA, investment, licensing, life sciences, manufacturing, pharmaceuticals, stem cells 
The Food and Drug Administration gave an emergency authorization for a self-collected Covid-19 diagnostic test, the first such test for home use. . . . → Read More: FDA Grants Emergency Clearance for Home Covid-19 Test Comments are closed New products, Regulations biotechnology, Covid-19, FDA, life sciences, medical device 
Clinical trial results of an amyotrophic lateral sclerosis, or ALS, therapy do not show slower disease progression among patients compared to a placebo. . . . → Read More: ALS Stem Cell Therapy Fails to Meet Trial Objective Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, FDA, life sciences, pharmaceuticals, stem cells 
A test to detect Covid-19 viruses in saliva rather than nasal swabs received emergency authorization from Food and Drug Administration. . . . → Read More: Covid-19 Saliva Test Earns FDA Emergency Clearance One comment - (Comments are closed) New products, Regulations biomedical, cancer, Covid-19, FDA, genomics, life sciences, medical device, university 
Food and Drug Administration issued new regulatory guidance designed to enroll clinical trial participants more representative of the populations they claim to serve. . . . → Read More: FDA Issues Guidance to Boost Clinical Trial Diversity |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||